IKS

Inventurus Knowledge Solutions Limited

Revenue cycle and clinical documentation services for US healthcare providers

Information Technology›Information Technology›IT - Services›IT Enabled Services

ikshealth.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1731.40
Market cap
29,581 Cr
Stock P/E
38.7
P/B
10.56
ROE (FY26)
25.8%
ROCE (FY26)
28.3%
Operating margin (FY26)
30.3%
Debt / equity (FY26)
0.23
OCF / EBITDA (FY26)
61.7%
OCF / EBITDA (3Y)
50.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

IKS Health (Inventurus Knowledge Solutions) provides technology-enabled services to US healthcare providers, including physician enterprises and health systems, to help them improve revenue and cut expenses.

Company snapshot

2ndBy market cap

Ranked among 56 companies in IT Enabled Services.

What we see

Positives
  • ✓Net margin of 22.6% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales657 Cr724 Cr740 Cr781 Cr815 Cr858 Cr894 Cr
Operating expenses (approx.)476 Cr498 Cr502 Cr509 Cr533 Cr557 Cr599 Cr
EBITDA181 Cr226 Cr238 Cr272 Cr282 Cr300 Cr295 Cr
OPM %27.6%31.2%32.1%34.8%34.6%35.0%33.0%
Other income27 Cr3 Cr3 Cr4 Cr6 Cr5 Cr6 Cr
Interest21 Cr21 Cr18 Cr16 Cr23 Cr13 Cr10 Cr
Depreciation28 Cr28 Cr28 Cr30 Cr32 Cr34 Cr34 Cr
Profit before tax160 Cr180 Cr195 Cr228 Cr229 Cr253 Cr251 Cr
Tax %19.0%17.9%22.2%20.6%20.1%18.6%22.8%
Net profit130 Cr148 Cr152 Cr181 Cr183 Cr206 Cr194 Cr
EPS (₹)₹7.80₹8.88₹9.07₹10.81₹10.96₹12.31₹11.55

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales764 Cr1,031 Cr1,818 Cr2,664 Cr3,194 CrSign in free for the trailing twelve months
Operating expenses (approx.)466 Cr640 Cr1,298 Cr1,894 Cr2,102 CrSign in free for the trailing twelve months
EBITDA297 Cr391 Cr520 Cr770 Cr1,091 CrSign in free for the trailing twelve months
OPM %38.9%37.9%28.6%28.9%34.2%Sign in free for the trailing twelve months
Other income21 Cr29 Cr40 Cr39 Cr17 CrSign in free for the trailing twelve months
Interest6 Cr5 Cr60 Cr90 Cr70 CrSign in free for the trailing twelve months
Depreciation23 Cr25 Cr59 Cr113 Cr124 CrSign in free for the trailing twelve months
Profit before tax269 Cr359 Cr442 Cr606 Cr905 CrSign in free for the trailing twelve months
Tax %13.2%15.1%16.1%19.8%20.3%Sign in free for the trailing twelve months
Net profit233 Cr305 Cr370 Cr486 Cr722 CrSign in free for the trailing twelve months
EPS (₹)₹14.26₹18.37₹22.37₹29.20₹43.12Sign in free for the trailing twelve months
Dividend payout %———0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital17 Cr17 Cr17 Cr17 Cr17 Cr
Reserves630 Cr812 Cr1,141 Cr1,773 Cr2,783 Cr
Borrowings——1,193 Cr755 Cr641 Cr
Other liabilities140 Cr160 Cr676 Cr507 Cr827 Cr
Total liabilities788 Cr988 Cr3,028 Cr3,052 Cr4,268 Cr
Fixed assets (net)26 Cr20 Cr52 Cr41 Cr54 Cr
CWIP——0.82 Cr5 Cr0 Cr
Investments16 Cr32 Cr195 Cr114 Cr377 Cr
Inventories——0.75 Cr0 Cr0.06 Cr
Trade receivables96 Cr161 Cr362 Cr532 Cr564 Cr
Cash & bank146 Cr124 Cr144 Cr180 Cr389 Cr
Other assets504 Cr652 Cr2,273 Cr2,179 Cr2,884 Cr
Total assets788 Cr988 Cr3,028 Cr3,052 Cr4,268 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity233 Cr288 Cr210 Cr318 Cr674 Cr
Cash from investing-82 Cr-156 Cr-1,141 Cr244 Cr-210 Cr
Cash from financing-59 Cr-152 Cr780 Cr-389 Cr-412 Cr
Net cash flow92 Cr-20 Cr-151 Cr170 Cr39 Cr
Free cash flow (OCF − Capex)222 Cr280 Cr177 Cr276 Cr642 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %42.5%44.0%21.3%27.4%28.3%
ROE %36.0%36.8%32.0%27.2%25.8%
Debtor days4657737364
Inventory days——000
Days payable58141017
Cash conversion cycle4149596247
OCF / EBITDA %78.4%73.6%40.3%41.3%61.7%
OCF / EBITDA % (3 years)——60.5%48.5%50.4%
Debt / equity——1.030.420.23
Current ratio5.566.071.141.501.42
Net debt / EBITDA-0.49-0.322.020.750.23